)
Echo IQ (EIQ) investor relations material
Echo IQ Investor update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business and financial position
Raised AUD 110 million, strengthening the balance sheet and enabling commercial expansion and R&D acceleration.
Operating cash burn remains stable at AUD 2.5–2.7 million per quarter, with pro forma cash at AUD 107.6 million post-raise.
Strong capital position supports scaling, product development, and FDA launch preparations.
Commercial progress and pipeline
Over 70 customers in various contract phases, representing about 300 hospitals, with rapid deal closure expected.
Fivefold increase in pricing proposals and contracts in review, driven by new EchoSolv VIEW and SHADOW programs.
Streamlined implementation and multithreaded sales approach accelerating book-to-bill and revenue recognition.
Enterprise deals could provide access to over 300 hospitals, with adoption spreading from single centers to networks.
Strategic partnerships and data assets
Strategic partnership with Pro Medicus includes AUD 10 million upfront and future revenue sharing, with integration into Visage 7 PACS.
Acquisition of Advara HeartCare data, one of the largest global databases, enhances competitive moat and AI capabilities.
Collaboration with Mayo Clinic includes both clinical validation (VALIDATE) and a three-year commercial agreement, with potential for extension.
- Strategic partnerships and $110m funding drive rapid US expansion and AI adoption.EIQ
Q4 2026 TU - Mayo Clinic and Mount Sinai deals drive U.S. expansion as FDA clearance and revenue ramp near.EIQ
Investor update - EchoSolv AS achieves rapid US adoption and pipeline growth, with solid cash reserves for expansion.EIQ
Q3 2026 TU - Net loss increased to $8.66 million amid key clinical and regulatory milestones for US expansion.EIQ
H1 2026 - EchoSolv HF clinical validation and FDA submission mark pivotal US market progress; cash at $13.21m.EIQ
Q2 2026 TU - AI-driven heart diagnostics poised for major U.S. expansion and revenue inflection in 2026.EIQ
Life Sciences Virtual Investor Forum 2025 - EchoSolv HF nears FDA submission as US adoption surges and cash reserves remain strong.EIQ
Q1 2026 TU - AI-driven heart disease diagnosis platform achieves near-perfect accuracy and rapid U.S. adoption.EIQ
Piper Sandler 37th Annual Healthcare Conference - AI platform validated at 99.5% sensitivity, FDA submission imminent, and rapid US market adoption expected.EIQ
Status Update
Next Echo IQ earnings date
Next Echo IQ earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)